Skip to main content

Table 1 Characteristics of subjects who underwent CT scan and subsequent liver biopsy to evaluate the correlation of un-enhanced CT liver attenuation to chemically derived liver triglyceride data

From: Non-contrasted Computed Tomography for the Accurate Measurement of Liver Steatosis in Obese Patients

Characteristics Subject number
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Sex Female Female Female Female Male Male Female Female Male Male Female Female Female Female Female
Age (years) 58 34 30 46 32 21 45 62 27 59 56 54 51 44 32
BMI (kg/m2) 48.5 39.4 38.3 42.5 47.0 40.6 51.5 40.5 45.5 46.6 46.7 38.2 49.7 42.1 48.4
Diabetes mellitus No Yes No No Yes No No No No Yes No Yes No No Yes
Liver TG (mg/g PR) 227 178 54 2,203 465 217 494 140 302 222 1,080 412 791 92 322
Plasma TG (mg/dl) 126 193 166 208 226 186 158 89 62 125 25 258 157 92 118
Plasma total chol (mg/dl) 186 213 169 211 168 126 178 153 106 1,230 65 156 119 149 136
Plasma LDL Chol (mg/dl) 146 152 116 171 128 74 125 109 73 93 27 88 66 111 95
Plasma HDL chol (mg/dl) 27 35 41 29 20 31 35 39 31 27 37 38 42 32 31
Plasma VLDL chol (mg/dl) 13 26 12 11 21 21 17 5 2 10 1 30 11 6 10
Macrosteatosis grade (0–4) 0 0 0 3 1 1 1 1 1 1 2 1 1 0 1
Inflammatory grade (0–4) 0 1 1 2 0 0 3 1 0 0 2 2 1 0 1
Ballooning (0–4) 0 0 0 2 1 0 1 1 0 0 2 1 1 0 2
Nash activity score (NAS) 0 1 1 7 2 1 5 3 1 1 6 4 3 0 4
Fibrosis stage (1–4) 0 0 0 1 0 1 3 0 1 2 3 1 0 0 3
  1. TG triglyceride, chol cholesterol